Japanese Firm Partners with Saudi Hospital for Innovative Stem Cell Therapy
Collaboration aims to bring new treatment options for intractable diseases and establish Saudi Arabia as a medical hub.
Tokyo-based Cytori Cell Research Institute, Inc. has entered into an agreement with the King Abdullah International Medical Research Center to advance stem cell therapy through a joint clinical trial.
The partnership seeks to address the growing number of patients with chronic conditions in the Middle East that are difficult to treat with conventional methods.ADR Therapeutics, a subsidiary of Cytori Cell Research Institute, is known for its 'Cellution System,' which can purify non-cultured cells within 90 minutes and administer them on the same day.
This approach offers quicker treatment than traditional stem cell therapy, where cells are cultured for several weeks or months at specialized facilities.The alliance aims to enhance medical innovation in Saudi Arabia as part of Vision 2030, a national strategy focused on making the country a global leader in healthcare.
Chronic diseases such as diabetes and osteoarthritis, which require new treatment options, are becoming increasingly prevalent due to lifestyle changes.Saudi doctors will receive training from Japanese specialists to ensure the successful implementation of this technology at local medical institutions.
This initiative is expected not only to improve access to advanced regenerative medicine but also to contribute significantly to healthcare services in areas with limited resources.
The partnership seeks to address the growing number of patients with chronic conditions in the Middle East that are difficult to treat with conventional methods.ADR Therapeutics, a subsidiary of Cytori Cell Research Institute, is known for its 'Cellution System,' which can purify non-cultured cells within 90 minutes and administer them on the same day.
This approach offers quicker treatment than traditional stem cell therapy, where cells are cultured for several weeks or months at specialized facilities.The alliance aims to enhance medical innovation in Saudi Arabia as part of Vision 2030, a national strategy focused on making the country a global leader in healthcare.
Chronic diseases such as diabetes and osteoarthritis, which require new treatment options, are becoming increasingly prevalent due to lifestyle changes.Saudi doctors will receive training from Japanese specialists to ensure the successful implementation of this technology at local medical institutions.
This initiative is expected not only to improve access to advanced regenerative medicine but also to contribute significantly to healthcare services in areas with limited resources.
